Through sheer determination, Neena Nizar has become the first patient in a clinical trial testing a treatment for her disease — one so rare it affects just 30 people worldwide.
Previous Story
AI Slop Is Everywhere. Spotify, LinkedIn and Others Have Had Enough.
Next Story
Jaguars Are Ready to Come Back. The Border Wall Might Stop Them.